Targeting the CXCR4/CXCL12 axis in systemic lupus erythematosus (Q37577890)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on October 2009

Language	Label	Description	Also known as
English	Targeting the CXCR4/CXCL12 axis in systemic lupus erythematosus	scientific article published on October 2009

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

1 reference

Europe PubMed Central

Targeting the CXCR4/CXCL12 axis in systemic lupus erythematosus (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

systemic lupus erythematosus

1 reference

based on heuristic

inferred from title

author name string

Benjamin F Chong

1

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

Chandra Mohan

2

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

language of work or name

0 references

publication date

1 October 2009

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

Expert Opinion on Therapeutic Targets

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

1147-1153

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

Systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

21 January 2018

Anti-DNA antibody production by CD5+ and CD5- B cells of patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

21 January 2018

A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

21 January 2018

B cells from patients with systemic lupus erythematosus display abnormal antigen receptor-mediated early signal transduction events

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

21 January 2018

Regulation of B cell tolerance by the lupus susceptibility gene Ly108.

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

21 January 2018

An open study of B lymphocyte depletion in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

21 January 2018

Identification of a B cell differentiation factor(s) spontaneously produced by proliferating T cells in murine lupus strains of the lpr/lpr genotype

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

21 January 2018

The contribution of L3T4+ T cells to lymphoproliferation and autoantibody production in MRL-lpr/lpr mice

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

21 January 2018

The resistance of activated T-cells from SLE patients to apoptosis induced by human thymic stromal cells

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

21 January 2018

An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

21 January 2018

Treatment of murine lupus with CTLA4Ig

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

21 January 2018

Lymphocyte homing and homeostasis

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

21 January 2018

Chemokines and chemokine receptors in leukocyte trafficking

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

21 January 2018

CXC chemokine ligand 12 promotes CCR7-dependent naive T cell trafficking to lymph nodes and Peyer's patches

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

21 January 2018

A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1)

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

21 January 2018

The chemokine SDF-1alpha triggers a chemotactic response and induces cell polarization in human B lymphocytes.

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

21 January 2018

The chemokine SDF-1, stromal cell-derived factor 1, attracts early stage B cell precursors via the chemokine receptor CXCR4.

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

21 January 2018

Identification and expression of novel isoforms of human stromal cell-derived factor 1.

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

21 January 2018

Efficient interaction of HIV-1 with purified dendritic cells via multiple chemokine coreceptors

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

21 January 2018

Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

21 January 2018

Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

21 January 2018

Mice deficient in the chemokine receptor CXCR4 exhibit impaired limb innervation and myogenesis

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

21 January 2018

The alpha-chemokine, stromal cell-derived factor-1alpha, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

21 January 2018

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

21 January 2018

The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

21 January 2018

The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

21 January 2018

The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

21 January 2018

Efficient inhibition of SDF-1alpha-mediated chemotaxis and HIV-1 infection by novel CXCR4 antagonists

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

21 January 2018

A duodenally absorbable CXC chemokine receptor 4 antagonist, KRH-1636, exhibits a potent and selective anti-HIV-1 activity

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

21 January 2018

Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

21 January 2018

High expression of the chemokine receptor CXCR4 predicts extramedullary organ infiltration in childhood acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

21 January 2018

Involvement of chemokine receptors in breast cancer metastasis

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

21 January 2018

The significance of cancer cell expression of the chemokine receptor CXCR4.

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

21 January 2018

CXCR4 is a major chemokine receptor on glioma cells and mediates their survival

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

21 January 2018

CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

21 January 2018

The anti-cancer compound Nordy inhibits CXCR4-mediated production of IL-8 and VEGF by malignant human glioma cells

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

21 January 2018

Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

21 January 2018

Translating an Antagonist of Chemokine Receptor CXCR4: from bench to bedside

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

21 January 2018

AMD3100, a potent and specific antagonist of the stromal cell-derived factor-1 chemokine receptor CXCR4, inhibits autoimmune joint inflammation in IFN-gamma receptor-deficient mice.

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

21 January 2018

Pro-inflammatory properties of stromal cell-derived factor-1 (CXCL12) in collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

21 January 2018

CXCR4/CXCL12 hyperexpression plays a pivotal role in the pathogenesis of lupus.

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

21 January 2018

Induction of a systemic lupus erythematosus-like disease in mice by a common human anti-DNA idiotype

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

21 January 2018

The mechanism by which a peptide based on complementarity-determining region-1 of a pathogenic anti-DNA auto-Ab ameliorates experimental systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

21 January 2018

Differential expression of chemokine receptors on peripheral blood B cells from patients with rheumatoid arthritis and systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

21 January 2018

Ultraviolet radiation-induced injury, chemokines, and leukocyte recruitment: An amplification cycle triggering cutaneous lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

21 January 2018

Pharmacokinetics and pharmacodynamics of plerixafor in patients with non-Hodgkin lymphoma and multiple myeloma

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

21 January 2018

Multiple-dose escalation study of the safety, pharmacokinetics, and biologic activity of oral AMD070, a selective CXCR4 receptor inhibitor, in human subjects

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

21 January 2018

Assessment: the use of natalizumab (Tysabri) for the treatment of multiple sclerosis (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

21 January 2018

Identifiers

10.1517/14728220903196761

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37577890&oldid=2142062477"